28/02/2013 02:15:00

EADS Chief Leaves Door Ajar for Another BAE Try

Related content

The chief executive of European Aeronautic Defense & Space Co. (EAD.FR) has left the door ajar for the revival of a blockbuster merger with BAE Systems PLC (BA.LN), the Times in London reported on its website Thursday.

Tom Enders, the German head of the Airbus manufacturer, said that a decision on EADS's ambitions to expand its defense interests--potentially in a tie-up with BAE--would be made after the completion of a strategic review of its military business and the shake-up of the group's board this spring, the Times said. Any new move, he indicated, wasn't imminent, the Times said.

The two companies abandoned a prior try at a merger.

Write to Dennis Baker at dennis.baker@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

February 27, 2013 21:15 ET (02:15 GMT)

Copyright (c) 2013 Dow Jones & Company, Inc.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

Form 8.5 (EPT/RI) - Tesco plc

21/08/2017 07:43:02
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY 1.         KEY INFORMATION (a) Name of exempt principal trader:   Investec Bank plc   (b) Name of offeror/offeree in relation to whose relevant se..

Majedie Asset Management Ltd : Form 8.3 - TESCO PLC

18/08/2017 15:36:47
FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser: ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Prima BioMed Appoints Non-Executive Director to the Board
2
Gamers Get First Chance to Play Xbox One X at GameStop Expo
3
Saniona AB: Saniona's partner, Medix, initiates Phase 3 study for tesofensine in obesity
4
Cecilie B. Heuch appointed EVP and Chief People Officer of Telenor Group
5
Novartis and Medicines for Malaria Venture launch patient trial in Africa for KAF156, a novel compound against multidrug-resistant malaria

Related stock quotes

BAE Systems PLC ORD 2.5P 584.50 0.2% Stock price increasing

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
21 August 2017 13:07:50
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170808.1 - EUROWEB2 - 2017-08-21 14:07:50 - 2017-08-21 13:07:50 - 1000 - Website: OKAY